ニュース

Serena Williams is opening up about her fitness journey, revealing that she has lost 31 pounds using the injectable GLP-1 ...
Serena Williams reveals her use of GLP-1, Zepbound and calls out the stigma surrounding the use of the popular weight loss ...
Tennis champion Serena Williams has divided the internet after revealing she’s been using a GLP-1 weight loss drug. The ...
Serena Williams has a new doubles partner. The 23-time Grand Slam tennis champion is working with Ro, speaking out about how ...
Serena Williams has revealed she lost 31 pounds on the GLP-1 Zepbound: "I just couldn't get my weight to where I needed to be at a healthy place." ...
A former college athlete, 51-year-old Charles never thought he'd have to worry about his weight. But football injuries and a ...
For decades, fitness influencers and athletes swore by “clean eating” and intense workouts as the ultimate path to weight loss and peak performance. But Serena Williams’s revelation signals a ...
Tricare officials said the Defense Health Agency is eliminating coverage for its Tricare for Life beneficiaries and others to "align with federal coverage requirements." ...
Through innovation, cost discipline, legal action, and competitive pricing, Novo Nordisk has reasserted its leadership in the GLP-1 market. With a robust pipeline and global expansion, NVO is poised ...
In April 2025 , Northstrive Biosciences announced it received preliminary feedback from the FDA on its planned Type B pre-IND ...
The integration aims to simplify access to Zepbound for eligible members while providing comprehensive, whole-person care to ...
GLP-1 drugs for diabetes and weight loss may influence patients’ cancer risk, usually lowering it but sometimes possibly ...